Are bipolar II disorder and polycystic ovary syndrome (PCOS) common in women of reproductive age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Are Bipolar II Disorder and PCOS Common in Women of Reproductive Age?

Yes, both conditions are common in women of reproductive age, with PCOS affecting up to 15% of reproductive-age women and showing a particularly strong association with bipolar disorder—women with PCOS face approximately double the risk of bipolar disorder compared to women without PCOS. 1, 2

Prevalence of PCOS

  • PCOS affects up to 15% of women in the reproductive age, making it one of the most common endocrine disorders in this population 1
  • Secondary amenorrhea (a common PCOS manifestation) affects approximately 3-4% of women in the general population, with PCOS being one of the most frequent underlying causes alongside functional hypothalamic amenorrhea, ovarian failure, and hyperprolactinemia 3
  • PCOS accounts for approximately 20-35% of cases of secondary amenorrhea and about 3% of primary amenorrhea cases 3

Prevalence of Bipolar Disorder in Women with PCOS

  • The pooled prevalence of bipolar disorder specifically in women with PCOS is 4% (95% CI, 2-5%), based on a meta-analysis of 73,102 women with PCOS 2
  • Women with PCOS have approximately 2-fold increased odds of bipolar disorder (pooled OR 2.06; 95% CI, 1.61-2.63) compared to women without PCOS 2
  • Individual studies report bipolar disorder prevalence in PCOS populations ranging from 0% to 27%, reflecting significant heterogeneity across populations 2
  • A separate meta-analysis confirmed elevated risk, showing women with PCOS are more likely to have a clinical diagnosis of bipolar disorder (OR 1.78; 95% CI, 1.43-2.23) 1

The Bidirectional Relationship

  • Women with bipolar disorder also show high prevalence of PCOS even before diagnosis or treatment of the psychiatric condition, suggesting shared pathophysiological mechanisms rather than purely medication-induced effects 4
  • Common metabolic and immune disorders—including hypothalamic-pituitary-adrenal axis dysfunction, chronic inflammation, gut microbial alterations, adipokine disturbances, and circadian rhythm disruption—are observed in both BD and PCOS, potentially explaining the comorbidity 4
  • Valproate, a common mood stabilizer for bipolar disorder, can trigger or exacerbate PCOS, including worsening hirsutism, creating a treatment-related pathway for the association 5, 6

Other Psychiatric Comorbidities in PCOS

Beyond bipolar disorder, women with PCOS face elevated risk of multiple psychiatric conditions:

  • Depression: OR 2.79 (95% CI, 2.23-3.50) 1
  • Anxiety: OR 2.75 (95% CI, 2.10-3.60) 1
  • Obsessive-compulsive disorder: OR 1.37 (95% CI, 1.22-1.55) 1
  • A nationwide cohort study found significantly increased incidence of newly diagnosed depressive disorder (HR 1.296), anxiety disorder (HR 1.392), and sleep disorder (HR 1.495) following PCOS diagnosis 7

Clinical Implications

  • Screening for psychiatric disorders, including bipolar disorder, in women with PCOS is warranted to allow early intervention 1
  • The temporal relationship appears bidirectional, with PCOS potentially increasing risk of subsequent psychiatric diagnoses and bipolar disorder increasing vulnerability to PCOS 4, 7
  • Women with bipolar disorder of reproductive age require careful mood stabilizer selection, as valproate carries the highest teratogenic risk in pregnancy and can worsen PCOS features 8
  • The association persists across all follow-up durations (0-1 years, 1-5 years, ≥5 years), indicating a sustained rather than transient relationship 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.